Tallman MS - Search Results

1

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, Löwenberg B, Bloomfield CD. Döhner H, et al. Among authors: tallman ms. Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28. Blood. 2017. PMID: 27895058 Free PMC article. Review.

2

A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.

Tallman MS, Hakimian D, Variakojis D, Koslow D, Sisney GA, Rademaker AW, Rose E, Kaul K. Tallman MS, et al. Blood. 1992 Nov 1;80(9):2203-9. Blood. 1992. PMID: 1358262 Free article.

3

Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.

Tallman MS, Kwaan HC. Tallman MS, et al. Blood. 1992 Feb 1;79(3):543-53. Blood. 1992. PMID: 1732003 Free article. Review. No abstract available.

4

Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.

Tallman MS, Kopecky KJ, Amos D, Dahlberg S, Hewlett JS, Files JC, Coltman CA, Thomas ED, Appelbaum FR. Tallman MS, et al. J Clin Oncol. 1989 Mar;7(3):326-37. doi: 10.1200/JCO.1989.7.3.326. J Clin Oncol. 1989. PMID: 2645386

5

Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.

Tallman MS, Nemunaitis JJ, McGuire TR, Yee GC, Hughes TE, Almgren JD, Appelbaum FR, Higano CS, McGuffin RW, Singer JW, et al. Tallman MS, et al. Transplantation. 1988 Apr;45(4):810-3. Transplantation. 1988. PMID: 3282363 No abstract available.

6

The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.

Clift RA, Buckner CD, Thomas ED, Kopecky KJ, Appelbaum FR, Tallman M, Storb R, Sanders J, Sullivan K, Banaji M, et al. Clift RA, et al. Bone Marrow Transplant. 1987 Oct;2(3):243-58. Bone Marrow Transplant. 1987. PMID: 3332174

7

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

8

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine.

Wheaton S, Tallman MS, Hakimian D, Peterson L. Wheaton S, et al. Among authors: tallman ms. Blood. 1996 Feb 15;87(4):1556-60. Blood. 1996. PMID: 8608247 Free article.

9

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1997 Aug 15;90(4):1656-63. Blood. 1997. PMID: 9269786 Free article. Clinical Trial.

10

All-trans-retinoic acid in acute promyelocytic leukemia.

Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH. Tallman MS, et al. N Engl J Med. 1997 Oct 9;337(15):1021-8. doi: 10.1056/NEJM199710093371501. N Engl J Med. 1997. PMID: 9321529 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

666 results

Search Page